L. Roy Papp & Associates’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Other funds holding RARE
L. Roy Papp & Associates's RARE Position: Q3 2026 in Review
L. Roy Papp & Associates opened a new position in Ultragenyx Pharmaceutical (RARE) in Q3 2026: 70,700 shares worth $1.06M. The stake represents 0.11% of the portfolio and ranks #93 among its holdings.
186 funds tracked by Wall St. Rank hold RARE as of Q3 2026.
- L. Roy Papp & Associates held 70,700 shares of Ultragenyx Pharmaceutical worth $1.06M as of Q3 2026.
- Ultragenyx Pharmaceutical was a new L. Roy Papp & Associates position in Q3 2026.
- Ultragenyx Pharmaceutical made up 0.11% of L. Roy Papp & Associates's portfolio in Q3 2026, its #93 holding.
- 186 funds tracked by Wall St. Rank held Ultragenyx Pharmaceutical as of Q3 2026.
Based on L. Roy Papp & Associates's 13F filing for Q3 2026, filed 21 Oct 2026.